Qiao Liu Selected Research

Hypersensitivity (Allergy)

8/2020	Progress in experimental research on SPRED protein family.
1/2019	Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiao Liu Research Topics

Disease

59	Neoplasms (Cancer) 07/2024 - 02/2006
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2019
17	Tuberculosis (Tuberculoses) 12/2024 - 01/2013
16	Inflammation (Inflammations) 04/2024 - 05/2012
14	Infections 04/2024 - 04/2012
12	Breast Neoplasms (Breast Cancer) 07/2024 - 11/2012
11	Hypoxia (Hypoxemia) 05/2024 - 09/2011
11	Neoplasm Metastasis (Metastasis) 01/2024 - 02/2006
10	COVID-19 10/2023 - 01/2020
6	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2015
5	Carcinogenesis 07/2024 - 12/2012
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2024 - 01/2015
4	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 11/2010
4	Leukemia 01/2023 - 10/2017
4	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2022
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2017
4	Lung Neoplasms (Lung Cancer) 01/2023 - 02/2006
3	Cardiomegaly (Heart Hypertrophy) 05/2024 - 07/2022
3	Hypertrophy 03/2024 - 07/2022
3	Fibrosis (Cirrhosis) 03/2024 - 12/2023
3	Triple Negative Breast Neoplasms 03/2024 - 07/2015
3	Melanoma (Melanoma, Malignant) 01/2024 - 01/2021
3	Hemorrhage 11/2023 - 01/2011
3	Glioma (Gliomas) 11/2023 - 01/2014
3	Tetralogy of Fallot (Fallot Tetralogy) 10/2023 - 01/2022
3	Lung Diseases (Lung Disease) 09/2023 - 01/2020
3	Mpox (monkeypox) 01/2023 - 01/2023
3	Asthma (Bronchial Asthma) 01/2023 - 01/2018
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2012
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 05/2019
3	Esophageal Neoplasms (Esophageal Cancer) 01/2011 - 01/2007
2	Dehydration (Water Stress) 04/2024 - 04/2023
2	Latent Tuberculosis 04/2024 - 10/2020
2	Type 2 Diabetes Mellitus (MODY) 03/2024 - 10/2023
2	Liver Diseases (Liver Disease) 03/2024 - 06/2022
2	Hypertension (High Blood Pressure) 03/2024 - 04/2020
2	Weight Gain 03/2024 - 08/2021
2	Communicable Diseases (Infectious Diseases) 02/2024 - 01/2023
2	Thrombosis (Thrombus) 01/2024 - 01/2020
2	Pulmonary Tuberculosis 12/2023 - 01/2019
2	Atherosclerosis 12/2023 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2023 - 10/2018
2	Epilepsy (Aura) 11/2023 - 03/2021
2	Fatigue 10/2023 - 03/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 07/2024 - 02/2006
9	AntioxidantsIBA 04/2024 - 01/2016
8	VaccinesIBA 10/2023 - 01/2007
8	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2023 - 09/2011
7	BerberineIBA 01/2019 - 03/2009
6	Tuberculin (PPD)IBA 04/2024 - 11/2017
6	PlatinumIBA 01/2024 - 01/2021
6	EnzymesIBA 01/2022 - 04/2012
5	Rifampin (Rifampicin)FDA LinkGeneric 12/2024 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 07/2024 - 04/2011
5	LipidsIBA 04/2024 - 04/2020
5	pembrolizumabIBA 01/2023 - 12/2019
5	MicroRNAs (MicroRNA)IBA 11/2022 - 10/2018
5	NivolumabIBA 01/2022 - 02/2020
4	Hormones (Hormone)IBA 07/2024 - 01/2017
4	AntigensIBA 01/2024 - 02/2006
4	atezolizumabIBA 01/2024 - 01/2021
4	Therapeutic UsesIBA 11/2023 - 10/2017
4	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 10/2013
4	Immune Checkpoint InhibitorsIBA 01/2023 - 02/2020
4	Docetaxel (Taxotere)FDA Link 11/2022 - 02/2020
4	AlkaloidsIBA 10/2017 - 03/2009
3	Estrogens (Estrogen)FDA Link 07/2024 - 03/2016
3	Peptides (Polypeptides)IBA 05/2024 - 12/2021
3	CarbohydratesIBA 04/2024 - 12/2021
3	Acetates (Acetic Acid Esters)FDA Link 04/2024 - 12/2023
3	matrigelIBA 03/2024 - 11/2019
3	Glycoproteins (Glycoprotein)IBA 01/2024 - 05/2012
3	Particulate MatterIBA 12/2023 - 08/2022
3	CytokinesIBA 12/2023 - 01/2017
3	Oxygen (Dioxygen)IBA 10/2023 - 12/2022
3	COVID-19 VaccinesIBA 10/2023 - 11/2021
3	CaspasesIBA 06/2023 - 01/2023
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 07/2020
3	Indicators and Reagents (Reagents)IBA 01/2023 - 08/2015
3	Messenger RNA (mRNA)IBA 11/2022 - 12/2013
3	ResveratrolIBA 02/2021 - 11/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2020
3	IpilimumabIBA 01/2021 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 11/2020 - 02/2015
2	Estrogen ReceptorsIBA 07/2024 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 04/2024 - 01/2022
2	Isoniazid (Ftivazide)FDA LinkGeneric 04/2024 - 01/2015
2	phillyrinIBA 03/2024 - 07/2022
2	SaltsIBA 03/2024 - 12/2023
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024 - 01/2022
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2024 - 01/2022
2	camrelizumabIBA 12/2023 - 03/2023

Therapy/Procedure

26	Therapeutics 03/2024 - 02/2006
21	Drug Therapy (Chemotherapy) 01/2024 - 01/2011
9	Immunotherapy 04/2024 - 02/2006
4	Artificial Respiration (Mechanical Ventilation) 01/2023 - 11/2020
3	Glycemic Control 03/2024 - 11/2017
3	Aftercare (After-Treatment) 11/2022 - 01/2021
2	Hepatectomy 03/2024 - 01/2014